PubRank

Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain (IBDomics)

Clinical Trial ID NCT03689257

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03689257

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Universal sample preparation method for proteome analysis. Nat Methods 2009 16.88
2 Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004 14.78
3 Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005 14.50
4 Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010 12.35
5 Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2011 12.09
6 Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998 6.36
7 Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut 2011 6.08
8 Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013 4.75
9 Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med 2013 3.98
10 Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014 3.97
11 Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 2003 1.37
12 East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2013 1.30
13 Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics 2006 1.30
14 Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2007 1.30
15 Immune surveillance properties of human NK cell-derived exosomes. J Immunol 2012 1.26
16 Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J Proteome Res 2007 1.13
17 Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics 2002 1.13
18 Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharmacol 2006 1.10
19 Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol 2013 1.07
20 Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol 2015 1.07
21 Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides. Inflamm Bowel Dis 2010 1.06
22 Proteomic analysis of the intestinal epithelial cell response to enteropathogenic Escherichia coli. J Biol Chem 2004 1.02
23 Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface. Inflamm Bowel Dis 2011 0.97
24 Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988. J Clin Gastroenterol 1994 0.96
25 Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl 2013 0.92
26 Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis. Rapid Commun Mass Spectrom 2007 0.91
27 Phenotypic and functional characterization of intestinal epithelial exosomes. Blood Cells Mol Dis 2005 0.90
28 Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease. J Gastroenterol 2010 0.90
29 Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohns Colitis 2014 0.89
30 [Epidemiologic study of Crohn's disease in the Asturian region]. Rev Esp Enferm Apar Dig 1983 0.87
31 Differential proteomic analysis of HT29 Cl.16E and intestinal epithelial cells by LC ESI/QTOF mass spectrometry. J Proteomics 2009 0.87
32 Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases. Clin Immunol 2015 0.86
33 New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflamm Bowel Dis 2010 0.85
34 Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease. J Dig Dis 2013 0.84
35 Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev Esp Enferm Dig 2004 0.82
36 [Epidemiologic study of Crohn's disease in Galicia from 1976 to 1983]. Rev Esp Enferm Apar Dig 1984 0.82
37 Epidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol 2014 0.80
38 Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study. Inflamm Bowel Dis 2015 0.80
39 Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis. J Crohns Colitis 2015 0.79
40 Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig 2009 0.79
41 [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain]. Gastroenterol Hepatol 2000 0.78
42 Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study. Gastroenterol Hepatol 2015 0.77
43 Integrating omics: the future of IBD? Dig Dis 2014 0.77
44 Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg 2014 0.76
45 Epidemiological aspects of inflammatory bowel disease in the Pamplona area. Rev Esp Enferm Dig 1999 0.76
46 Incidence of inflammatory bowel disease in the 02 health area of Castellon (1992-1996). Rev Esp Enferm Dig 1999 0.75
47 [Chronic inflammatory intestinal disease in Catalonia (Barcelona and Gerona)]. Rev Esp Enferm Dig 1992 0.75
48 [A descriptive epidemiological study of ulcerative colitis in a community hospital (1985-1989)]. Med Clin (Barc) 1991 0.75
49 [Incidence of inflammatory bowel disease in the health area of Navalmoral de la Mata (Caceres, Spain) between 2000 and 2009]. Gastroenterol Hepatol 2010 0.75
50 [Incidence of inflammatory bowel disease in Sagunto]. Rev Esp Enferm Dig 1990 0.75
51 [Intestinal inflammatory disease in the province of Soria. Retrospective clinical and epidemiologic study from 1981 to 1990]. Rev Esp Enferm Dig 1992 0.75
52 Crohn's disease in Galicia, Spain. Scand J Gastroenterol Suppl 1989 0.75
Next 100